Journal Paper
| Year |
Paper Title |
| 2027 |
ChihDuo Hong*;YenPeng Chen;Fang Yu, 2027.01, 'Signature filtering: A lightweight enhancement for statistical watermark detection in large language models, ' Information Processing and Management, Vol.64, No.1, pp.104998.(ACM, DBLP, SCI)(*為通訊作者), vol. 146054, Jan. 2027 |
| 2026 |
張士傑;葉永濬;李彥寬*, 2026.12, '台灣壽險業新一代清償能力制度下 資產配置與監理措施分析, ' 中山管理評論, Vol.34, No.4, pp.1-34.(TSSCI)(*為通訊作者), vol. 143465, Dec. 2026 |
| 2026 |
Hyewon Ma*;Joseph T. Mahoney;譚丹琪, 2026.10, 'The complementarities of dynamic capabilities and multinational switching options, ' International Business Review, Vol.35, No.5, pp.102606.(SSCI)(*為通訊作者), vol. 147630, Oct. 2026 |
| 2026 |
胡昌亞;Mai Pham*;Yen-Yu Chen;Patrick F. Bruning, 2026.10, 'A Meta-Analysis of Incremental, Comparative, and Conditional Motivations of Unethical Pro-Organizational Behavior, ' Journal of Business Research, pp.1-17.(SSCI)(*為通訊作者), vol. 102221, Oct. 2026 |
| 2026 |
Hsu, Fu-Hsuan;Chia-Ling Lee*;Fang Gong;Chih-Yu Chuang, 2026.09, 'Does corporate AI adoption improve investment efficiency? Evidence from textual analysis of 10-K filings, ' Finance Research Letters, Vol.107, pp.110366.(SSCI)(*為通訊作者), vol. 148238, Sep. 2026 |
| 2026 |
Wei-Yu Kuo;Ya-Chien Lin;Sha-Wei Zhang*, 2026.09, 'Assessing the Market Timing Ability of Mutual Fund Investors in Taiwan, ' Review of Securities and Futures Markets, Vol.38, No.3, pp.59-94.(TSSCI)(*為通訊作者), vol. 147582, Sep. 2026 |
| 2026 |
Sheng-Syan Chen;黃嘉威*, 2026.08, 'Opacity Opportunism: The Effect of Private Benefits of Control on Voluntary Disclosure, ' Journal of International Money and Finance, Vol.168, No.September, pp.103652.(SSCI)(*為通訊作者)(本論著未刊登但已被接受), vol. 147722, Aug. 2026 |
| 2026 |
Lin, Wen-Ting;Chia-Ling Lee*;David Ahlstrom, 2026.08, 'CEO narcissism and TMT characteristics: The moderating role of task complexity, ' Review of Managerial Science, pp.1-50.(SSCI)(*為通訊作者), vol. 144655, Aug. 2026 |
| 2026 |
Ping-Hsun Chen*, 2026.08, 'Drafting a Pharmaceutical Composition Claim Covering Later-Developed Combination Drugs Without Losing the Disclosure Requirement Challenge: In re Entresto, 125 F.4th 1090 (Fed. Cir. 2025), ' Biotechnology Law Report, Vol.45, No.4, pp.254-262.(SCIE)(*為通訊作者), vol. 147725, Aug. 2026 |
| 2026 |
Gordon W. Cheung*;Changya Hu;Elena Zubielevitch, 2026.08, 'Assessing partial measurement invariance in cross-group, longitudinal, congruence, and multilevel organizational studies: Introducing the MEI package in R, ' Organizational Research Methods, pp.1-35.(SSCI)(*為通訊作者), vol. 139017, Aug. 2026 |
Powered by RulingDigital
